The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 4,379,753 | 232,718 | SH | SOLE | 232,718 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,486,564 | 27,389 | SH | SOLE | 27,389 | 0 | 0 | |||
BAXTER INTL INC | COM | 071813109 | 6,773,520 | 167,000 | SH | SOLE | 167,000 | 0 | 0 | |||
BIOGEN INC | COM | 09062X103 | 24,421,043 | 87,836 | SH | SOLE | 87,836 | 0 | 0 | |||
BIO RAD LABS INC | CL A | 090572207 | 6,522,815 | 13,617 | SH | SOLE | 13,617 | 0 | 0 | |||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 15,203,474 | 156,350 | SH | SOLE | 156,350 | 0 | 0 | |||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 31,159,766 | 449,571 | SH | SOLE | 449,571 | 0 | 0 | |||
BIONTECH SE | SPONSORED ADS | 09075V102 | 3,307,832 | 26,554 | SH | SOLE | 26,554 | 0 | 0 | |||
BRUKER CORP | COM | 116794108 | 12,071,744 | 153,117 | SH | SOLE | 153,117 | 0 | 0 | |||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 8,124,722 | 162,397 | SH | SOLE | 162,397 | 0 | 0 | |||
CARDINAL HEALTH INC | COM | 14149Y108 | 28,440,926 | 376,701 | SH | SOLE | 376,701 | 0 | 0 | |||
CENTENE CORP DEL | COM | 15135B101 | 15,091,135 | 238,746 | SH | SOLE | 238,746 | 0 | 0 | |||
CATALENT INC | COM | 148806102 | 9,889,421 | 150,501 | SH | SOLE | 150,501 | 0 | 0 | |||
CVS HEALTH CORP | COM | 126650100 | 2,846,816 | 38,310 | SH | SOLE | 38,310 | 0 | 0 | |||
ELEVANCE HEALTH INC | COM | 036752103 | 16,451,542 | 35,779 | SH | SOLE | 35,779 | 0 | 0 | |||
EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 13,138,020 | 158,806 | SH | SOLE | 158,806 | 0 | 0 | |||
GILEAD SCIENCES INC | COM | 375558103 | 45,033,876 | 542,773 | SH | SOLE | 542,773 | 0 | 0 | |||
ILLUMINA INC | COM | 452327109 | 5,506,086 | 23,677 | SH | SOLE | 23,677 | 0 | 0 | |||
INCYTE CORP | COM | 45337C102 | 31,237,623 | 432,235 | SH | SOLE | 432,235 | 0 | 0 | |||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 5,233,801 | 146,441 | SH | SOLE | 146,441 | 0 | 0 | |||
LABORATORY CORP AMER HLDGS | COM NEW | 50540R409 | 18,678,229 | 81,415 | SH | SOLE | 81,415 | 0 | 0 | |||
MEDTRONIC PLC | SHS | G5960L103 | 25,710,040 | 318,904 | SH | SOLE | 318,904 | 0 | 0 | |||
MERCK & CO INC | COM | 58933Y105 | 5,974,118 | 56,153 | SH | SOLE | 56,153 | 0 | 0 | |||
NUVASIVE INC | COM | 670704105 | 9,656,460 | 233,756 | SH | SOLE | 233,756 | 0 | 0 | |||
PTC THERAPEUTICS INC | COM | 69366J200 | 2,659,647 | 54,906 | SH | SOLE | 54,906 | 0 | 0 | |||
QIAGEN NV | SHS NEW | N72482123 | 11,977,947 | 260,787 | SH | SOLE | 260,787 | 0 | 0 | |||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 4,261,908 | 106,282 | SH | SOLE | 106,282 | 0 | 0 | |||
SEAGEN INC | COM | 81181C104 | 7,288,920 | 36,000 | SH | SOLE | 36,000 | 0 | 0 | |||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 9,817,788 | 165,227 | SH | SOLE | 165,227 | 0 | 0 | |||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 3,386,832 | 145,545 | SH | SOLE | 145,545 | 0 | 0 | |||
ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | 22,752,508 | 176,103 | SH | SOLE | 176,103 | 0 | 0 |